Cipla 517 50 MG Pill - blue & white capsule/oblong, 19mm
Pill with imprint Cipla 517 50 MG is Blue & White, Capsule/Oblong and has been identified as Cyclophosphamide 50 mg. It is supplied by Cipla USA Inc.
Cyclophosphamide is used in the treatment of Acute Lymphocytic Leukemia; Acute Nonlymphocytic Leukemia; Breast Cancer; Cancer; Chronic Lymphocytic Leukemia and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Cyclophosphamide 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Cipla 517 50 MG
Cyclophosphamide
- Imprint
- Cipla 517 50 MG
- Strength
- 50 mg
- Color
- Blue & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0517
More about cyclophosphamide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Patient resources
- Cyclophosphamide oral and injection drug information
- Cyclophosphamide (Advanced Reading)
- Cyclophosphamide Tablets
- Cyclophosphamide Capsules
Other brands
Cytoxan, Neosar, Cytoxan Lyophilized
Professional resources
- Cyclophosphamide monograph
- Cyclophosphamide (FDA)
- Cyclophosphamide Capsules (FDA)
- Cyclophosphamide Concentrate Injection (FDA)
- Cyclophosphamide Injection (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
